ZURICH A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, according to a study, aiding the Swiss group's bid to win approval in a niche disease area before rivals that now dominate the immunotherapy market.
ZURICH, Sept 25 A drug cocktail with Roche's
Tecentriq added two months to small-cell lung cancer
patients' lives, potentially aiding the Swiss company's bid to
win approval in a niche disease area before rivals that now
dominate the immunotherapy market.
ZURICH Novartis will cut 2,550 jobs in Switzerland and Britain over four years, it said on Tuesday, as the Swiss drugmaker strives to boost profits and focus on new medicines.
ZURICH Drug giants Novartis , Bayer and Roche on Friday lost a bid to stop British doctors from recommending a cheaper drug option for people with an eye disease that causes blindness, the High Court in London ruled.
ZURICH, Sept 21 A European Medicines Agency
panel recommended approval of Spark Therapeutics' gene
therapy for blindness, a move that also boosts Swiss drugmaker
Novartis that bought the rights to one of the world's
costliest treatments outside the United States.
ZURICH Swiss drugmaker Novartis has revealed its employees only get a bonus if they meet or exceed expectations for ethical behavior as it seeks to address past shortcomings that have damaged its reputation.
ZURICH Credit Suisse failed to adequately combat money laundering in suspected corruption cases linked to soccer's ruling body FIFA and Venezuelan and Brazilian state oil companies, Switzerland's financial watchdog FINMA said on Monday, dealing a blow to the bank's reputation. | Video
LONDON/ZURICH, Sept 13 Roche, the
world's biggest producer of cancer drugs, is stepping up cost
cuts in an efficiency drive made unavoidable by competition from
cut-price copies of three mega-brands from its famed U.S.
Genentech biotech stable.